Caffeine Consumption and Rosacea Risk: What's the Link?

By October 17, 2018

Participants who responded to a question related to rosacea diagnosis in 2005 were included in the final analysis (N=82,737).

Sustained Use of Oxymetazoline Cream Efficacious for Rosacea

May 17, 2018

The researchers found that 8.2% of patients reported treatment-emergent adverse events (TEAEs), the most common were application site dermatitis, paresthesia, pain, and pruritus. Several authors disclosed financial ties to Allergan, which is a manufacturer of oxymetazoline.

Newly Designed Pulsed-Dye Laser Found Effective for Rosacea

April 20, 2018

The average improvement was 53.9%. Reported side effects included mild edema, mild-to-moderate erythema, and mild-to-moderate bruising.

Tentative Approval Granted for Generic Rosacea Cream

By January 30, 2018

Ivermectin cream is a semi-synthetic derivative isolated from the fermentation of Streptomyces avermitilis that belongs to the avermectin family of macrocyclic lactones.

Link Between Obesity and Rosacea Examined for First Time

December 11, 2017

The risk for rosacea was higher among those with increased body mass index (BMI; P<0.0001).

<i>H. Pylori</i> Treatment May Also Improve This Skin Condition

May 08, 2017

Significant decrease in most criteria of rosacea Duluth score in patients cured of H. pylori infection

Out-of-Pocket Spending for Topical Steroids Investigated

May 02, 2017

The researchers found that patients' out-of-pocket spending for topical steroids was $333.7 million. There was a 226.5% increase in total annual spending, from $237.6 million to $775.9 million.

Rhofade Available for Persistent Redness with Rosacea

By April 19, 2017

Rhofade applied once-daily demonstrated a reduction in persistent facial erythema associated with rosacea through 12 hours in both clinical trials.

Economic Impact of Skin Disease Highlighted in New Report

March 03, 2017

In the United States, dermatological conditions cost 75 billion in 2013, researchers say

New Topical Cream Approved for Persistent Redness with Rosacea

By January 19, 2017

Allergan announced that the Food and Drug Adminisration (FDA) has approved Rhofade (oxymetazoline HCl) cream for the topical treatment of persistent facial erythema associated with rosacea in adults.

Expert Panel Provides Recommendations for Rosacea Treatment

November 21, 2016

For patients with rosacea, phenotype-based treatments should be given for presenting signs and symptoms, according to updated treatment guidelines published online in the British Journal of Dermatology.

FDA to Review Topical Rosacea Treatment

By May 24, 2016

The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for oxymetazoline HCl cream 1% (Allergan) for the treatment of persistent facial erythema associated with rosacea in adults.

Mirvaso Gel Available in New Pump Delivery System

By May 19, 2016

Mirvaso (brimonidine; Galderma) Topical Gel 0.33% is now available in a pump dispenser.

Rosacea Txs Assessed to Measure Health-Related Quality of Life Improvement

April 14, 2016

For patients with rosacea, ivermectin treatment is associated with long-term improvement in health-related quality of life (HRQoL).

Shared Parkinson's Pathogens Highlight Possible Risk of Onset With Rosacea

March 22, 2016

Rosacea is associated with an increased risk for Parkinson's disease, according to research published online in JAMA Neurology.

<i>H. cinaedi</i> Bacteremia Tied to Recurrent Eythema, Rosacea

February 10, 2016

Recurrent superficial cellulitis-like erythema is associated with Helicobacter cinaedi (H. cinaedi) bacteremia, according to a case report published online in The Journal of Dermatology.

New Oral Rosacea Drug Gains Tentative FDA Approval

By February 01, 2016

Dr. Reddy's Laboratories announced that the Food and Drug Administration (FDA) has granted tentative approval for Zenavod (doxycycline) capsules for the treatment of only inflammatory lesions (papules and pustules) of rosacea in adults.

New Treatment for Rosacea Launched

By October 26, 2015

Bayer HealthCare announced the launch of Finacea Foam (azelaic acid) 15% for the topical treatment of the inflammatory papules and pustules of mild to moderate rosacea.

Rosacea Linked to Various Comorbid Conditions

September 24, 2015

Rosacea is associated with various comorbid conditions, including, but not limited to, allergies, respiratory diseases, and gastrointestinal diseases.

Genetics, Environment Could Contribute to Rosacea Equally

September 10, 2015

Risk of rosacea appears to be half environmental and half genetic, with sun exposure, body mass index, smoking, alcohol consumption, and cardiovascular comorbidity key contributors.

Finacea Foam Approved for Rosacea

By July 31, 2015

Bayer HealthCare announced that the Food and Drug Administration (FDA) has approved Finacea (azelaic acid) Foam 15% for the topical treatment of inflammatory papules and pustules of mild to moderate rosacea.

Standard Tx for Rosacea May Not Be Superior

April 07, 2015

For patients with papulopustular rosacea (PPR), once-daily ivermectin 1 percent cream (IVM 1 percent) is superior to twice-daily metronidazole (MTZ 0.75 percent) cream, according to a new study.

Telangiectatic Photoaging Distinct From Rosacea Subtype

March 23, 2015

Histological, gene expression findings differentiate TP from erythematotelangiectatic rosacea

New Rosacea Tx Option Now Available

By February 17, 2015

Galderma announced the availability of Soolantra (ivermectin) Cream for the the treatment of rosacea.

Propranolol, Doxycycline Combo Evaluated for Rosacea

January 13, 2015

For patients with rosacea, combination treatment with propranolol and doxycycline appears to be effective and safe.

Once-Daily Topical Cream for Rosacea Approved

By December 23, 2014

Galderma announced that the Food and Drug Administration (FDA) has approved Soolantra (ivermectin) Cream for the topical treatment of inflammatory lesions of rosacea.

Rapid-Absorbing Rosacea Cream Now Available

June 04, 2014

Quest Products announced the launch of ProVent Rosacea Moisturizing Creme indicated to help reduce the appearance of skin often associated with rosacea and other skin conditions.

Positive Results Announced for Rosacea Treatment

March 24, 2014

Galderma announced results from two Phase 3 trials of ivermectin 1%, an investigational drug being evaluated for the treatment of papulopusular rosacea.

Teledermatology Is Reliable for Initial Triage Consultations

February 18, 2014

Teledermatology is reliable for initial triage of patients, according to a study published online.

Mirvaso Shows Positive Long-Term Study Results

January 30, 2014

Galderma has announced that in a one-year, open-label, non-comparative study, Mirvaso (brimonidine) topical gel was demonstrated to be safe and effective when used once daily for up to 12 months.